Patents by Inventor Xavier Codony Soler

Xavier Codony Soler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9782483
    Abstract: The invention refers to the use of a sigma ligand, preferably a sigma ligand of formula (I), to prevent or treat emesis induced by a chemotherapeutic agent or radioactivity, especially emesis induced by taxanes, vinca alkaloids or platin chemotherapeutic drugs.
    Type: Grant
    Filed: May 20, 2011
    Date of Patent: October 10, 2017
    Assignee: Laboratories Del Dr. Esteve, S.A.
    Inventors: José Miguel Vela Hernández, Xavier Codony-Soler, Daniel Zamanillo-Castanedo
  • Publication number: 20130109692
    Abstract: The invention refers to the use of a sigma ligand, preferably a sigma ligand of formula (I), to prevent or treat emesis induced by a chemotherapeutic agent or radioactivity, especially emesis induced by taxanes, vinca alkaloids or platin chemotherapeutic drugs.
    Type: Application
    Filed: May 20, 2011
    Publication date: May 2, 2013
    Applicant: LABORATORIOS DEL DR. ESTEVE, S.A.
    Inventors: José Miguel Vela Hernández, Xavier Codony-Soler, Daniel Zamanillo-Castanedo
  • Publication number: 20120128768
    Abstract: The present invention relates to an active substance combination comprising at least one compound with neuropeptide Y-receptor affinity and at least one compound with 5-HT6 receptor affinity, a medicament comprising said active substance combination, and the use of said active substance combination for the manufacture of a medicament.
    Type: Application
    Filed: January 30, 2012
    Publication date: May 24, 2012
    Applicant: LABORATORIOS DEL DR. ESTEVE S.A
    Inventors: Antoni Torrens Jover, Josep Mas Prio, Alberto Dordal Zueras, Xavier Codony Soler, Ramon Merce Vidal, Jose-Aurelio Castrillo Perez, Jordi Frigola Constansa, Helmut-Heinrich Buschmann
  • Patent number: 8097643
    Abstract: The present invention refers to new sulfonamide derivatives, of general formula (1a, 1b, 1c), optionally in form of one of their stereoisomers, preferably enantiomers or diastereomers, their racemate, or in form of a mixture of at least two of their stereoisomers, preferably enantiomers or diastereomers, in any mixing ratio, or their salt thereof s, preferably the corresponding, physiologically acceptable salt thereofs, or corresponding solvate thereofs; to the processes for their preparation, to their application as medicaments in human and/or veterinary therapeutics, and to the pharmaceutical compositions containing them.
    Type: Grant
    Filed: July 29, 2004
    Date of Patent: January 17, 2012
    Assignee: Laboratorios del Dr. Esteve S. A.
    Inventors: Ramon Merce Vidal, Xavier Codony Soler, Alberto Dordal Zueras
  • Publication number: 20100120747
    Abstract: The present invention relates to an active substance combination comprising at least one compound with 5-HT6 receptor affinity, and at least one cholinesterase inhibitor, a medicament comprising said active substance combination, and the use of said active substance combination for the manufacture of a medicament.
    Type: Application
    Filed: June 22, 2007
    Publication date: May 13, 2010
    Applicant: Laboratorios del Dr. Esteve, S.A.
    Inventors: Xavier Codony-Soler, Helmut Heinrich Buschmann
  • Publication number: 20100074955
    Abstract: The present invention relates to an active substance combination comprising at least one compound with 5-HT6 receptor affinity, and at least NMDA-receptor ligand, a medicament comprising said active substance combination, and the use of said active substance combination for the manufacture of a medicament.
    Type: Application
    Filed: September 18, 2007
    Publication date: March 25, 2010
    Applicant: LABORATORIOS DEL DR. ESTEVE, S.A.
    Inventors: Helmut Heinrich Buschmann, Xavier Codony-Soler
  • Patent number: 7655690
    Abstract: The present invention refers to new sulfonamide derivatives, of general formula (Ia, Ib, Ic), (I), (Ia, Ib, Ic), optionally in form of one of their stereoisomers, preferably enantiomers or diastereomers, their racemate, or in form of a mixture of at least two of their stereoisomers, preferably enantiomers or diastereomers, in any mixing ratio, or their salts, preferably their corresponding physiologically acceptable salts or corresponding solvates; to the processes for their preparation, to their application as medicaments in human and/or veterinary therapeutics, and to the pharmaceutical compositions containing them. The new compounds of the present invention can be used in the pharmaceutical industry as intermediates and for preparing medicaments.
    Type: Grant
    Filed: July 29, 2004
    Date of Patent: February 2, 2010
    Assignee: Laboratorios del Dr. Esteve S.A.
    Inventors: Ramon Merce Vidal, Xavier Codony Soler, Alberto Dordal Zueras
  • Publication number: 20090264457
    Abstract: The present invention relates to a Combination of at least two 5HT6-Ligands of which one is a partial or agonist while the other is a full antagonist or an inverse agonist, a medicament comprising this comination, the use of the combiantion in the manufacture of a medicament for the treatment of memory disorders ADHD, and methods of treatment using the combination or its members.
    Type: Application
    Filed: August 1, 2008
    Publication date: October 22, 2009
    Inventors: Xavier Codony-Soler, Jose-Miguel Vela-Hernandez, Helmut H. Buschmann
  • Publication number: 20090005417
    Abstract: The present invention relates to substituted indazolyl sulfonamide and 2,3-dihydroindolyl sulfonamide compounds of general formula I, a process for their preparation, medicaments comprising said substituted indazolyl sulfonamide and 2,3-dihydro-indolyl sulfonamide compounds as well as the use of said substituted indazolyl sulfonamide and 2,3-dihydro-indolyl sulfonamide compounds for the preparation of medicaments, which are particularly suitable for the prophylaxis and/or treatment of disorders or diseases that are at least partially mediated via 5-HT6 receptors.
    Type: Application
    Filed: December 29, 2005
    Publication date: January 1, 2009
    Applicant: LABORATORIOS DEL DR. ESTEVE S.A.
    Inventors: Ramon Merce Vidal, Xavier Codony-Soler, Alberto Dordal-Zueras
  • Patent number: 7462640
    Abstract: The present invention refers to new sulfonamide derivatives, of general formula (Ia, Ib, Ic) optionally in form of one of their stereoisomers, preferably enantiomers or diastereomers, their racemate, or in form of a mixture of at least two of their stereoisomers, preferably enantiomers or diastereomers, at any mixing ratio or their salts, preferably the corresponding, physiologically acceptable salts, or corresponding solvates; to the process for their preparation, to their application as medicaments in human and/or veterinary therapeutics, and to the pharmaceutical compositions containing them.
    Type: Grant
    Filed: July 29, 2004
    Date of Patent: December 9, 2008
    Assignee: Laboratorios del Dr. Esteve S.A.
    Inventors: Ramon Merce Vidal, Xavier Codony Soler, Alberto Dordal Zueras
  • Patent number: 7414070
    Abstract: The present invention refers to new sulfonamide derivatives, of general formula (Ia, Ib, Ic), optionally in form of one of their stereoisomers, preferably enantiomers or diastereomers, their racemate, or in form of a mixture of at least two of their stereoisomers, preferably enantiomers or diastereomers, in any mixing ratio, or their salts, preferably the corresponding, physiologically acceptable salts, or corresponding solvates; to the processes for their preparation, to their application as medicaments in human and/or veterinary therapeutics, and to the pharmaceutical compositions containing them.
    Type: Grant
    Filed: July 29, 2004
    Date of Patent: August 19, 2008
    Assignee: Laboratorios del Dr. ESTEVE S.A.
    Inventors: Ramon Merce Vidal, Xavier Codony Soler, Alberto Dordal Zueras
  • Publication number: 20070203121
    Abstract: The present invention relates to substituted indole compounds of general formula (I), a process for their preparation, medicaments comprising substituted indole compounds as well as the use of substituted indole compounds for the preparation medicaments, which are suitable e.g., for the prophylaxis and/or treatment of disorders or diseases that are at least partially mediated via 5-HT6 receptors.
    Type: Application
    Filed: February 9, 2007
    Publication date: August 30, 2007
    Applicant: LABORATORIOS DEL DR. ESTEVE S.A
    Inventors: Ramon Merce Vidal, Alberto Dordal Zueras, Xavier Codony Soler
  • Publication number: 20070185158
    Abstract: The present invention refers to new sulfonamide derivatives, of general formula (1a, 1b, 1c), optionally in form of one of their stereoisomers, preferably enantiomers or diastereomers, their racemate, or in form of a mixture of at least two of their stereoisomers, preferably enantiomers or diastereomers, in any mixing ratio, or their salt thereof s, preferably the corresponding, physiologically acceptable salt thereofs, or corresponding solvate thereofs; to the processes for their preparation, to their application as medicaments in human and/or veterinary therapeutics, and to the pharmaceutical compositions containing them.
    Type: Application
    Filed: July 29, 2004
    Publication date: August 9, 2007
    Applicant: Laboratorios Del Dr. Esteve S.A
    Inventors: Ramon Merce Vidal, Xavier Codony Soler, Alberto Dordal Zueras
  • Publication number: 20070060581
    Abstract: The present invention refers to new sulfonamide derivatives, of general formula (Ia, Ib, Ic), (I), (Ia, Ib, Ic), optionally in form of one of their stereoisomers, preferably enantiomers or diastereomers, their racemate, or in form of a mixture of at least two of their stereoisomers, preferably enantiomers or diastereomers, in any mixing ratio, or their salts, preferably their corresponding physiologically acceptable salts or corresponding solvates; to the processes for their preparation, to their application as medicaments in human and/or veterinary therapeutics, and to the pharmaceutical compositions containing them. The new compounds of the present invention can be used in the pharmaceutical industry as intermediates and for preparing medicaments.
    Type: Application
    Filed: July 29, 2004
    Publication date: March 15, 2007
    Applicant: LABORATORIOS DEL DR. ESTEVE S.A.
    Inventors: Ramon Merce Vidal, Xavier Codony Soler, Alberto Dordal Zueras
  • Publication number: 20070059364
    Abstract: The present invention relates to an active substance combination comprising at least one compound with neuropeptide Y-receptor affinity and at least one compound with 5-HT6 receptor affinity, a medicament comprising said active substance combination, and the use of said active substance combination for the manufacture of a medicament.
    Type: Application
    Filed: July 29, 2004
    Publication date: March 15, 2007
    Applicant: Laboratorios Del Dr. Esteve S.A.
    Inventors: Antoni Torrens Jover, Josep Mas Prio, Alberto Dordal Zueras, Xavier Codony Soler, Ramon Merce Vidal, Jose-Aurello Castrillo Perez, Jordi Frigola Constansa, Helmut-Heinrich Buschmann
  • Publication number: 20070043041
    Abstract: The present invention refers to new sulfonamide derivatives, of general formula (la, lb, lc) optionally in form of one of their stereoisomers, preferably enantiomers or diastereomers, their racemate, or in form of a mixture of at least two of their stereoisomers, preferably enantiomers or diastereomers, at any mixing ratio or their salts, preferably the corresponding, physiologically acceptable salts, or corresponding solvates; to the process for their preparation, to their application as medicaments in human and/or veterinary therapeutics, and to the pharmaceutical compositions containing them.
    Type: Application
    Filed: July 29, 2004
    Publication date: February 22, 2007
    Inventors: Ramon Merce Vidal, Xavier Codony Soler, Alberto Dordal Zueras
  • Publication number: 20070032520
    Abstract: The present invention refers to new sulfonamide derivatives, of general formula (1a, 1b, 1c) optionally in form of one of their stereoisomers, preferably enantiomers or diastereomers, their racemate, or in form of a mixture of at least two of their stereoisomers, preferably enantiomers or diastereomers, in any mixing ratio, or their salts, preferably the corresponding, physiologically acceptable salts, or corresponding solvates; to the processes for their preparation, to their application as medicaments in human and/or veterinary therapeutics, and to the pharmaceutical compositions containing them.
    Type: Application
    Filed: July 29, 2004
    Publication date: February 8, 2007
    Applicant: Laboratorios Del Dr. Esteve S.A
    Inventors: Ramon Merce Vidal, Xavier Codony Soler, Alberto Dordal Zueras
  • Publication number: 20070009597
    Abstract: The present invention relates to an active substance combination comprising at least one compound with neuropeptide Y-receptor affinity, preferably neuropeptide Y5-receptor affinity, and at least one compound with 5-HT6 receptor affinity, a medicament comprising said active substance combination, and the use of said active substance combination for the manufacture of a medicament.
    Type: Application
    Filed: July 29, 2004
    Publication date: January 11, 2007
    Applicant: LABORATORIOS DEL DR. ESTEVE S.A.
    Inventors: Antoni Torrens Jover, Josep Mas Prio, Albert Dordal Zueras, Xavier Codony Soler, Ramon Merce Vidal, Jose-Aurello Castillo Perez, Jordi Frigola Constansa, Helmut-Heinrich Buschmann